Show
Sort by
-
Zoledronic acid add-on therapy for standard-risk Ewing sarcoma patients in the Ewing 2008R1 trial
-
- Journal Article
- A1
- open access
Process intensification education contributes to sustainable development goals : part 2
-
Process intensification education contributes to sustainable development goals : part 1
-
Impact of gender on efficacy and acute toxicity of alkylating agent based chemotherapy in Ewing sarcoma : secondary analysis of the Euro-Ewing99-R1 trial
-
Methotrexate, doxorubicin, and cisplatin (MAP) plus maintenance pegylated interferon alfa-2b versus MAP alone in patients with resectable high-grade osteosarcoma and good histologic response to preoperative MAP : first results of the EURAMOS-1 good respons randomized controlled trial